Inhibitory effects of total triterpenoids isolated from the Hedyotis diffusa willd on H1975 cells

Kenan Wu1, Xue Wu2, Yanni Liang1

  • 1Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, State Key Laboratory of Research and Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi University of Chinese Medicine, Xian Yang, China.

Insights

Total triterpenes from Hedyotis diffusa (TTH) inhibit non-small-cell lung cancer (NSCLC) cell proliferation and migration. TTH induces apoptosis by affecting Nuclear factor-κB (NF-κB) and Signal transducer and activator of transcription 3 (STAT3) pathways.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Non-small-cell lung cancer (NSCLC) is a leading cause of cancer death.
  • Nuclear factor-κB (NF-κB) and Signal transducer and activator of transcription 3 (STAT3) pathways are implicated in NSCLC proliferation.
  • Hedyotis diffusa (H. diffusa) is a traditional Chinese medicine used for tumors, but its mechanism in NSCLC is unclear.

Purpose of the Study:

  • To investigate the effects of total triterpenes from H. diffusa (TTH) on H1975 NSCLC cells.
  • To elucidate the underlying molecular mechanisms, focusing on cell proliferation, migration, and apoptosis.

Main Methods:

  • Cell-cycle analysis
  • Immunofluorescence assays
  • Western blotting to assess protein levels (Bcl-2, Bax, MMP-2, MMP-9, TIMP-2, phospho-STAT3, NF-κB).

Main Results:

  • TTH inhibited H1975 cell proliferation by causing G0/G1 cell-cycle arrest.
  • TTH induced apoptosis, evidenced by decreased Bcl-2 and increased Bax protein levels.
  • TTH reduced cell migration by downregulating MMP-2/MMP-9 and upregulating TIMP-2.
  • TTH treatment decreased phospho-STAT3 and nuclear NF-κB levels, while increasing cytoplasmic NF-κB.

Conclusions:

  • TTH effectively inhibits NSCLC cell proliferation and migration and induces apoptosis.
  • These effects are mediated through the modulation of NF-κB and STAT3 signaling pathways.
  • TTH shows potential as a therapeutic agent for NSCLC.

Related Concept Videos